Smartee Denti-Technology Expands Southeast Asian Footprint with Strategic Launch in Malaysia, Empowering Clinicians with AI-Driven Orthodontics
KUALA LUMPUR, Malaysia, March 27, 2026 /PRNewswire/ -- Smartee Denti-Technology, a global innovator in clear aligner solutions, has officially announced its strategic entry into Malaysia. The milestone was marked by a specialized full-day clinical conference at Hilton Kuala Lumpur on March 16, gathering over 70 dental professionals, including orthodontic specialists, general practitioners, and university faculty members from across the country....
Neutech Group Creates New Momentum for Ecological Growth in Education, Healthcare, and Wellness
HONG KONG and DALIAN, China, March 27, 2026 /PRNewswire/ -- On March 27, Neutech Group (Stock Code: 9616.HK) released its 2025 annual results. Its business segments of education, healthcare and elderly care developed in synergy, creating new momentum for ecological growth. During the Reporting Period, the Group recorded revenue of approximately RMB2.039 billion and adjusted net profit of approximately RMB407...
Beauty Farm Announces 2025 Annual Results: Net Profit Surges 41%, with Strong Cash Flow Growth
HONG KONG, March 27, 2026 /PRNewswire/ -- On March 27, Beauty Farm Medical and Health Industry Inc. (02373.HK, "Beauty Farm" or the "Group") announced its annual results for 2025. During the year, the Group achieved high-quality growth across revenue, profit, and cash flow, with robust performance underscoring the strong growth resilience of an industry leader. In 2025, Beauty...
Akeso Reports Full-Year 2025 Financial Results
HONG KONG, March 27, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced its 2025 annual results, highlighting a year of comprehensive, strategic leaps across all facets of its business. Commercial Operations Enter a New Phase of Growth In 2025, Akeso achieved record commercial sales revenue of RMB3,033.1 million, a 51.48% year-on-year increase. All approved products...
Zimmer Biomet Wins Three Awards at Healthcare Asia Medtech Awards 2026
Awards Recognize Innovations in Infection Measures, AI-Driven Recovery and Surgeon Engagement across Asia Pacific. SINGAPORE, March 27, 2026 /PRNewswire/ -- Zimmer Biomet (NYSE and SIX: ZBH), a global medical technology leader, today announced it received three awards at the Healthcare Asia Medtech Awards 2026, recognizing the company's innovations across orthopedic product development,...
Insilico Medicine and Tenacia Biotechnology Expand AI-Driven CNS Collaboration with Deal Value Up to US$94.75 Million
CAMBRIDGE, Mass., March 26, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, and Tenacia Biotechnology (Hong Kong) Co., Limited ("Tenacia"), a commercial-stage biopharmaceutical company dedicated to developing innovative therapeutics for patients with underserved neurological disorders, today announced that, building on the productive collaboration over the past year, the two parties will further...
MINISH Veneers to Host U.S. CE Course in California, Expanding Biomimetic Dentistry Training to North America
LOS ANGELES, March 26, 2026 /PRNewswire/ -- Health-tech company MINISH Veneers USA announced that it will host its upcoming U.S. MINISH Veneers Course from May 8 to 10, 2026, at the VITA North America training center in Brea, California. MINISH Veneers Training Course The three-day program is an officially recognized Continuing Education (CE) course designed for dental professionals...
Keymed Biosciences Announces 2025 Annual Results and Business Updates
BEIJING, March 26, 2026 /PRNewswire/ -- Keymed Biosciences (HKEX: 02162) announced its 2025 annual results. The year marked the company's 10th anniversary and a pivotal year in its transition from R&D to commercialization. Revenue Leaps Forward, Supporting Long-Term Stable Growth Since its founding in 2016, Keymed has built a pipeline of over 50 programs, with more than 10 in...
CStone Announces 2025 Annual Results: Accelerated Expansion of Global Commercial Footprint and Efficient Advancement of Innovation Pipeline 2.0
Rapid Advancement Across Core R&D Pipeline The global, multicenter Phase I/II clinical trial of CS2009 (PD-1/VEGF/CTLA-4 trispecific antibody) is actively enrolling patients in Australia and China, and the Phase II IND application has been approved in the US. CS2009 demonstrates an excellent safety profile with a ≥Grade 3 TRAE rate of 23%, along with broad-spectrum anti-tumor activity. Notably,...
HealYou Built a Mental Health Platform for the Millions of Asians Who Would Never Use One
Asia is rewriting mental health — and the West may not be ready for what comes next TAIPEI and NEW YORK, March 26, 2026 /PRNewswire/ -- In America, Chinese Communities Are Quietly Rewriting the Rules of Mental Health Chinese Online Therapist For decades, the global mental health system has been shaped by a...
